Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising.
ModernaModerna(US:MRNA) Barrons·2026-02-18 14:27

The U.S. Food and Drug Administration will review the investigational seasonal flu vaccine candidate after rejecting it earlier this month. ...

Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising. - Reportify